Hologic, Inc. Stock
Stocks
HOLX
US4364401012
Advanced Medical Equipment & Technology
|
Market Closed -
Nasdaq
16:00:00 2026-04-06 EDT
|
5-day change | 1st Jan Change | ||
| 76.01 USD | +0.48% |
|
-.--% | +2.04% |
| 07-30 | Quest Diagnostics And Hologic, Inc. Conduct National Health Trends Study On Bacterial Vaginosis And STI Co-Infection | CI |
| 06-30 | Hologic Recalls BioZorb Implantable Markers, FDA Says | MT |
| Market Cap | 16.97B 14.66B 13.79B 12.53B 23.57B 1,626B 23.92B 162B 63.39B 813B 63.71B 62.33B 2,709B | P/E 2024 |
24.3x | P/E 2025 | 27x |
|---|---|---|---|---|---|
| Enterprise Value | 17.39B 15.02B 14.13B 12.84B 24.16B 1,666B 24.51B 166B 64.96B 833B 65.29B 63.87B 2,776B | EV / Sales 2024 |
4.74x | EV / Sales 2025 | 3.75x |
| Free-Float |
73.08% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Hologic, Inc.
| 1 day | +0.48% | ||
| 6 months | +1.08% | ||
| Current year | +2.04% |
| Current year | 74.49 |  | 76.07 |
| 1 year | 63.19 | | 76.07 |
| 3 years | 51.9 | | 84.67 |
| 5 years | 51.9 | | 87.88 |
| 10 years | 26.49 | | 87.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joe Almeida
CEO | Chief Executive Officer | 63 | 2026-04-06 |
Brian Montgomery
DFI | Director of Finance/CFO | - | 2026-04-15 |
Essex Mitchell
COO | Chief Operating Officer | 46 | 2023-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Joe Almeida
BRD | Director/Board Member | 63 | 2026-04-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 4/7/26 | Issuer sale | Director | 23,407 | 0.0105% | ||
| 2/27/26 | Tax | General Counsel | 185 | 0.0001% | ||
| 2/26/26 | Free | Director | 3,190 | 0.0014% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.48% | -.--% | +12.99% | +3.91% | 16.97B | |
| +0.60% | -2.64% | +20.82% | +10.64% | 216B | |
| -1.51% | -3.79% | -4.51% | -20.62% | 142B | |
| +0.22% | -2.50% | -18.72% | +36.80% | 138B | |
| -1.87% | -1.41% | -51.02% | +0.56% | 74.53B | |
| +0.19% | -2.86% | +16.19% | +18.80% | 52.34B | |
| +1.18% | -0.33% | -16.45% | -13.29% | 50.28B | |
| -0.01% | -0.70% | +25.64% | +24.48% | 41.93B | |
| -1.59% | -3.31% | +38.65% | +48.61% | 40.06B | |
| +0.36% | -0.16% | -0.74% | +6.25% | 32.69B | |
| Average | -0.20% | -1.56% | +2.28% | +11.61% | 80.56B | |
| Weighted average by Cap. | -0.21% | -2.24% | +0.40% | +9.98% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.03B 3.48B 3.28B 2.98B 5.6B 386B 5.68B 38.42B 15.06B 193B 15.13B 14.8B 643B | 4.1B 3.54B 3.33B 3.03B 5.7B 393B 5.78B 39.09B 15.32B 196B 15.4B 15.06B 655B |
| Net income | 790M 682M 642M 583M 1.1B 75.64B 1.11B 7.53B 2.95B 37.83B 2.96B 2.9B 126B | 566M 489M 460M 418M 786M 54.2B 797M 5.39B 2.11B 27.11B 2.12B 2.08B 90.3B |
| Net Debt | 321M 278M 261M 237M 446M 30.78B 453M 3.06B 1.2B 15.4B 1.21B 1.18B 51.28B | 421M 364M 342M 311M 585M 40.33B 593M 4.01B 1.57B 20.17B 1.58B 1.55B 67.18B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- HOLX Stock
Select your edition
All financial news and data tailored to specific country editions
